Adverse events1,956

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 40 of 1,956

Type	Event	Organ system	Group	Affected	At risk
other	Upper respiratory tract infection	Infections and infestations	Placebo/ Denosumab 60 mg Q6M	139	2,206
other	Upper respiratory tract infection	Infections and infestations	Denosumab/ Denosumab 60 mg Q6M	128	2,343
other	Urinary tract infection	Infections and infestations	Placebo/ Denosumab 60 mg Q6M	242	2,206
other	Urinary tract infection	Infections and infestations	Denosumab/ Denosumab 60 mg Q6M	250	2,343
other	Contusion	Injury, poisoning and procedural complications	Placebo/ Denosumab 60 mg Q6M	181	2,206
other	Contusion	Injury, poisoning and procedural complications	Denosumab/ Denosumab 60 mg Q6M	176	2,343
other	Fall	Injury, poisoning and procedural complications	Placebo/ Denosumab 60 mg Q6M	240	2,206
other	Fall	Injury, poisoning and procedural complications	Denosumab/ Denosumab 60 mg Q6M	268	2,343
other	Hypercholesterolaemia	Metabolism and nutrition disorders	Placebo/ Denosumab 60 mg Q6M	215	2,206
other	Hypercholesterolaemia	Metabolism and nutrition disorders	Denosumab/ Denosumab 60 mg Q6M	200	2,343
other	Arthralgia	Musculoskeletal and connective tissue disorders	Placebo/ Denosumab 60 mg Q6M	527	2,206
other	Arthralgia	Musculoskeletal and connective tissue disorders	Denosumab/ Denosumab 60 mg Q6M	541	2,343
other	Back pain	Musculoskeletal and connective tissue disorders	Placebo/ Denosumab 60 mg Q6M	501	2,206
other	Back pain	Musculoskeletal and connective tissue disorders	Denosumab/ Denosumab 60 mg Q6M	493	2,343
other	Musculoskeletal pain	Musculoskeletal and connective tissue disorders	Placebo/ Denosumab 60 mg Q6M	197	2,206
other	Musculoskeletal pain	Musculoskeletal and connective tissue disorders	Denosumab/ Denosumab 60 mg Q6M	231	2,343
other	Osteoarthritis	Musculoskeletal and connective tissue disorders	Placebo/ Denosumab 60 mg Q6M	332	2,206
other	Osteoarthritis	Musculoskeletal and connective tissue disorders	Denosumab/ Denosumab 60 mg Q6M	355	2,343
other	Pain in extremity	Musculoskeletal and connective tissue disorders	Placebo/ Denosumab 60 mg Q6M	264	2,206
other	Pain in extremity	Musculoskeletal and connective tissue disorders	Denosumab/ Denosumab 60 mg Q6M	293	2,343

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00523341/events?page=2

API reference For AI assistants